Beamtree Holdings Ltd (ASX: BMT) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Beamtree Holdings Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Beamtree Holdings Ltd (ASX: BMT)
Latest News
Broker Notes
2 ASX small caps which could rise 140% to 150%
Ask a Fund Manager
2 small-cap ASX shares to handsomely reward patient investors
Technology Shares
Beamtree (ASX: BMT) share price rockets 21% on acquisition news
Frequently Asked Questions
-
No, Beamtree does not pay dividends at this time.
-
Beamtree Holdings Ltd listed on the ASX on 6 June 2019.
BMT ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Beamtree Holdings Ltd
Beamtree Holdings Ltd (ASX: BMT) is a technology company involved in health data analytics. Its software incorporates artificial intelligence and machine learning to provide an integrated platform for information and knowledge management for health providers.
Beamtree's platform offers end-to-end support from data collection and classification through quality and performance benchmarking to clinical decision support at point of care.
The company says its products help healthcare providers to meet critical challenges in four key areas: rising demand, financial decision-making, quality of clinical outcomes, and patient experience.
BMT Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 11 Nov 2026 | $0.07 | $0.00 | 0.00% | 62,158 | $0.07 | $0.07 | $0.07 |
| 10 Nov 2026 | $0.07 | $0.00 | 0.00% | 215,086 | $0.07 | $0.07 | $0.07 |
| 09 Nov 2026 | $0.07 | $0.00 | 0.00% | 715,466 | $0.07 | $0.07 | $0.07 |
| 06 Nov 2026 | $0.07 | $0.00 | 0.00% | 232,139 | $0.06 | $0.07 | $0.06 |
| 05 Nov 2026 | $0.07 | $0.00 | 0.00% | 326,523 | $0.07 | $0.07 | $0.07 |
| 04 Nov 2026 | $0.06 | $0.00 | 0.00% | 259,353 | $0.07 | $0.07 | $0.06 |
| 03 Nov 2026 | $0.07 | $0.00 | 0.00% | 198,226 | $0.07 | $0.07 | $0.06 |
| 02 Nov 2026 | $0.07 | $0.00 | 0.00% | 149,961 | $0.07 | $0.07 | $0.07 |
| 30 Oct 2026 | $0.07 | $0.00 | 0.00% | 616,503 | $0.07 | $0.08 | $0.07 |
| 29 Oct 2026 | $0.07 | $-0.01 | -12.99% | 123,592 | $0.08 | $0.08 | $0.07 |
| 28 Oct 2026 | $0.08 | $0.00 | 0.00% | 104,638 | $0.08 | $0.08 | $0.08 |
| 27 Oct 2026 | $0.08 | $0.00 | 0.00% | 72,726 | $0.08 | $0.08 | $0.08 |
| 26 Oct 2026 | $0.08 | $0.00 | 0.00% | 11,638 | $0.08 | $0.08 | $0.08 |
| 23 Oct 2026 | $0.08 | $-0.01 | -11.24% | 253,246 | $0.09 | $0.09 | $0.08 |
| 22 Oct 2026 | $0.09 | $0.00 | 0.00% | 5,000 | $0.09 | $0.09 | $0.09 |
| 21 Oct 2026 | $0.09 | $0.00 | 0.00% | 5,000 | $0.09 | $0.09 | $0.09 |
| 16 Oct 2026 | $0.09 | $0.00 | 0.00% | 76,100 | $0.09 | $0.09 | $0.09 |
| 15 Oct 2026 | $0.09 | $0.00 | 0.00% | 1,075 | $0.09 | $0.09 | $0.09 |
| 14 Oct 2026 | $0.09 | $0.00 | 0.00% | 68,000 | $0.09 | $0.09 | $0.09 |
| 13 Oct 2026 | $0.09 | $0.00 | 0.00% | 8,000 | $0.09 | $0.09 | $0.09 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 03 Sep 2026 | Michael (Mike) Hill | Buy | 86,000 | $9,890 |
On-market trade.
|
| 31 Aug 2026 | Martin Bowles | Buy | 80,000 | $9,600 |
On-market trade.
|
| 30 Jun 2026 | Jim Birch | Transfer | 75,510 | $10,571 |
Off-market transfer. Assuming off market transfer
|
| 30 Jun 2026 | Jim Birch | Transfer | 75,510 | $10,571 |
Off-market transfer. Assuming off market transfer
|
| 23 Jun 2026 | Michael (Mike) Hill | Buy | 68,970 | $10,000 |
On-market trade.
|
| 23 Jun 2026 | Michael (Mike) Hill | Transfer | 75,510 | $10,571 |
Off-market transfer. Assuming off market transfer
|
| 23 Jun 2026 | Michael (Mike) Hill | Transfer | 75,510 | $10,571 |
Off-market transfer. Assuming off market transfer
|
| 22 Jun 2026 | Martin Bowles | Buy | 596,774 | $86,532 |
On-market trade.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Michael (Mike) Hastings Hill | Non-Executive Director | Jun 2018 |
Mr Hill has been involved in working with management teams and boards across several companies and industries for more than 20 years. He is the MD & CIO, Founder of the Bombora Special Investment Growth Fund. Prior to Bombora he was an Investment Partner with Ironbridge, a private equity investment fund. Michael has served as Chairman of multiple ASX-listed companies over the past nine years. He is a member of the Institute of Chartered Accountants in Australia.
|
| Ms Emma Gray | Executive ChairmanExecutive Director | Nov 2022 |
Ms Gray is a business executive with over 20 years of experience in operations, strategy and digital transformation in the retail, consumer and banking sectors. Emma was with ANZ Banking Group for 5 years, most recently as Group Executive, Data and Automation having previously been its Chief Data Officer. Prior to joining ANZ, Emma was a Group Executive with Woolworths, where she focused on Loyalty, Data and Strategy. Prior to executive life, Emma was a partner with Bain & Company, where she specialized in the retail and consumer segments, working across Australia, the United States and the United Kingdom for 15 years.
|
| Professor Andrew(Andy) Ian Hardy | Non-Executive Director | Mar 2025 |
Prof Hardy is Chief Executive Officer of University Hospitals Coventry and Warwickshire NHS Trust (UHCW). Andy was appointed Chief Executive Officer in 2010. For the six years prior to that he was Chief Finance Officer of UHCW, as well as Deputy Chief Executive Officer from 2008-2010. In January 2016 Andy was appointed Professor of Industry at the University of Warwick and in 2022 awarded the Honorary Degree of Doctor of Business Administration at Coventry University in recognition of his leadership and contribution to healthcare provision across Coventry and Warwickshire. In April 2023 he accepted the appointment of Professor for the Vice Chancellor Health Advisory Board, Coventry University. In August 2023, He was appointed as Deputy Chair for the newly established National Improvement Board. Working closely with Chair, David Fillingham CBE, he leads and supports the identification and delivery of national improvement priorities in line with NHS IMPACT and associated improvement approaches.
|
| Mr Stuart MacDonald | Non-Executive Director | Oct 2025 |
Mr MacDonald is a senior technology executive with 30 years in the technology sector and more than 20 years of global leadership experience across the U.S., UK, Middle East and Asia-Pacific. Since 2017 he has served as Chief Operating Officer of TechnologyOne Limited, where he has helped drive the companyshift from on-premises licences to a market-leading SaaS platform and scale its international growth, particularly in the UK. At TechnologyOne, Mr MacDonald has led several signature innovations that have strengthened the company competitive position and customer outcomes. He architected SaaS, a one-fee, full-implementation operating model that compresses deployment timelines and accelerates time-to-value; delivered a company-wide brand modernisation and simplified go-to-market to reinforce SaaS leadership; and conceived and spearheaded Plus, Technology One AI embedding natural language insights and agentic automation across the ERP suite. Prior to TechnologyOne, Mr MacDonald held senior leadership roles at Infor Global Solutions.
|
| Mr Martin Bowles | Non-Executive Director | Mar 2026 |
-
|
| Mr Gareth Pye | Chief Executive Officer | Jul 2026 |
-
|
| Ms Maria Clemente | Company Secretary | May 2024 |
-
|
| Gareth Pye | Chief Executive Officer |
-
|
|
| Maria Clemente | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| J P Morgan Nominees Australia Pty Limited | 47,940,537 | 16.50% |
| Jakeco Pty Ltd | 30,195,924 | 10.40% |
| Invia Custodian Pty Limited | 29,530,333 | 10.17% |
| HSBC Custody Nominees (Australia) Limited A/C 2 | 16,115,346 | 5.55% |
| Freestate Holdings Pty Ltd | 15,897,883 | 5.47% |
| Shorebrook Pty Limited | 9,773,500 | 3.36% |
| Sandtree Pty Ltd | 8,713,160 | 3.00% |
| HSBC Custody Nominees (Australia) Limited | 5,451,974 | 1.88% |
| BNP Paribas Nominees Pty Ltd | 4,998,295 | 1.72% |
| Netwealth Investments Limited | 3,756,782 | 1.29% |
| Citicorp Nominees Pty Limited | 3,277,859 | 1.13% |
| KM Fitzpatrick & Associates Pty Ltd | 3,230,000 | 1.11% |
| Dr Russell Kay Hancock | 3,200,000 | 1.10% |
| Brazil Farming Pty Ltd | 3,000,000 | 1.03% |
| Indcorp Consulting Group Pty Limited | 2,500,000 | 0.86% |
| Mrs Clare Elizabeth Mapledoram | 2,250,000 | 0.77% |
| Mr David Cameron Bambach | 2,073,545 | 0.71% |
| Ozren Tosic | 1,726,725 | 0.59% |
| Castlereagh Equity Pty Ltd | 1,550,000 | 0.53% |
| SMC Capital Pty Ltd | 1,550,000 | 0.53% |
| Jaspar Investments Pty Ltd | 1,349,936 | 0.46% |